Mexico’s nicotine market is changing. Oral nicotine pouches, which contain nicotine but do not require tobacco combustion, have become increasingly visible through online platforms and physical retailers. Their emergence raises legitimate questions about product standards, nicotine strength, marketing, youth protection and how these products fit within Mexico’s existing regulatory framework.
A recent commentary published on the Tobacco Control blog draws attention to these issues, documenting examples of nicotine pouch promotion in Mexico ranging from social-media advertising and free samples to reward programmes, sports-related imagery and products containing more than 30 mg of nicotine per pouch. The authors also cite Mexico’s 2025 National Survey on Drug, Alcohol and Tobacco Use (ENCODAT), which estimated 103,731 nicotine pouch users.
For GINN LatAm, the regulatory question is therefore becoming increasingly difficult to avoid: if nicotine pouches are present in the Mexican market, what framework can provide meaningful consumer and youth protections while recognising the differences between nicotine products?
A Regulatory Gap Needs Regulatory Clarity
Mexico has taken a restrictive approach towards several novel nicotine products, particularly electronic cigarettes and vaping devices. A 2022 federal decree prohibited the circulation and commercialisation of electronic nicotine-delivery systems, electronic cigarettes, vaping devices and related solutions and mixtures.
Nicotine pouches are different in design. They are placed between the gum and lip and involve neither combustion nor inhalation. The 2022 decree is specifically directed at electronic and vaporising systems and does not expressly identify oral nicotine pouches.
This distinction has practical consequences. Without a framework tailored to oral nicotine products, important questions around permissible nicotine levels, ingredients, manufacturing standards, labelling, age verification and marketing can remain unclear.
The Mexican legislature has continued to consider broader approaches. A proposal introduced in March 2026, for example, sought changes to the General Health Law covering nicotine products used through different routes, including provisions concerning packaging, promotion, ingredients and health protection. As of the latest legislative record, the proposal remained pending in committee.
Marketing and Youth Protection Deserve Attention
Some of the practices documented in Mexico warrant regulatory scrutiny regardless of the wider debate over harm reduction.
The Tobacco Control commentary identifies products using confectionery-style presentation, football and national imagery, promotions involving free samples and reward schemes, and offers linking nicotine pouches with alcoholic or energy drinks. It also documents products sold online at particularly high nicotine strengths.
A risk-proportionate approach does not require regulators to overlook these concerns. Measures designed to prevent sales to minors, restrict marketing likely to appeal particularly to young people, establish credible age verification and ensure consumers receive accurate product information can coexist with recognition of differences in relative risk.
Nicotine is addictive and nicotine pouches are not risk-free. Higher-strength products also deserve particular attention because nicotine delivery can vary substantially between products. Clear standards on nicotine content, ingredients and manufacturing quality would give regulators more effective tools than leaving such questions unresolved.
Product-Neutral Protection Should Not Mean Risk-Neutral Regulation
The authors of the Tobacco Control commentary argue that Mexico should adopt product-neutral restrictions covering advertising, promotion and sponsorship across nicotine products.
There is a reasonable case for common protections in certain areas. Age restrictions, enforcement against sales to minors and controls on marketing directed towards young people do not necessarily depend on whether nicotine is delivered through a cigarette, vape or oral pouch.
That does not mean every regulatory requirement should automatically be identical across all nicotine products.
Combustible cigarettes expose users to products of combustion. Nicotine pouches do not involve burning tobacco or inhaling smoke. Emerging research comparing the products has found substantially lower exposure to many harmful constituents from nicotine pouches than from cigarette smoking, although evidence on their long-term health effects remains limited.
Regulation should be capable of recognising both realities: nicotine pouches carry risks that require appropriate controls, while their risk profile should not automatically be assumed to be equivalent to that of combustible cigarettes.
Standards Can Address the Market More Directly
A clearer framework could establish basic requirements before products reach consumers.
These could include defined limits and disclosure requirements for nicotine content, ingredient and contaminant standards, manufacturing and quality-control requirements, appropriate health information, child-resistant packaging where justified, robust age verification for online and physical sales, and restrictions on marketing practices likely to appeal to minors.
Market surveillance and enforcement would be equally important. Formal standards have limited value if imported or non-compliant products with unusually high nicotine concentrations remain readily available through online channels.
Such an approach would also give legitimate manufacturers clearer expectations while providing authorities with defined standards against which products can be assessed.
An Opportunity for Evidence-Based Regulation in Mexico
The growth of nicotine pouches in Mexico presents policymakers with a choice about how an emerging product category should be governed.
The documented concerns around youth access, high nicotine strengths and marketing should not be dismissed. They strengthen the case for regulatory clarity and effective enforcement. At the same time, addressing those concerns does not require policymakers to disregard differences in toxicology and modes of nicotine delivery.
For Mexico, a more durable framework would distinguish between protecting people who do not use nicotine, particularly young people, and regulating products used by adults according to the evidence surrounding their risks.
As the evidence develops, regulation should be capable of developing with it. Clear product standards, responsible marketing rules, consumer information, youth safeguards and effective surveillance can provide stronger protection while preserving an important principle for nicotine policy across Latin America: regulation should respond to risk rather than assuming that all nicotine products are the same.
Sources
- Ponciano-Rodriguez G, Flores-Escalante V. Oral Nicotine Pouches in Mexico: how marketing exploits regulatory gaps. Tobacco Control Blog, 30 September 2026.
- Secretaría de Salud / CONASAMA. Encuesta Nacional de Consumo de Drogas, Alcohol y Tabaco (ENCODAT) 2025. Government of Mexico, 2025.
- Diario Oficial de la Federación. Decreto por el que se prohíbe la circulación y comercialización… de los Sistemas Electrónicos de Administración de Nicotina…, 31 May 2022.
- Sistema de Información Legislativa, Secretaría de Gobernación. Legislative proposal reforming provisions of the General Health Law concerning toxic substances and nicotine products, presented 24 March 2026.
